Gilbert Syndrome kit FL

Gilbert’s Syndrome (GS) is a form of chronic and moderate iperbilirubinemia (not conjugated) caused by a lower hepatic glucuronidation of bilirubin by UDP-glucuronosyltransferase 1 (UGT1A1) enzyme. Most patients affected by this disease are homozygous for a TA insertion in TATA-box of UGT1A1 gene promoter.

The Gilbert sydrome kit- FL amplifies the TATA-box contained in UGT1A1 (UDP-glucuronosyltransferase) gene promoter by a primers pair one of which is marked with a fluorescent dye. The amplicons are separated by capillary electrophoresis by an automatic sequencer. This technique allows, with an extremely accurate manner, to assess the length of amplicons and to distinguish mutated alleles from wild type alleles, also if they differs by only a base pair.

EXPERTEAM Gilbert tabla
Gilbert Syndrome kit FL 2

Area:

Gilbert Syndrome, Molecular Genetics, Targeted study of specific pathologies

Technology:

Brand:

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)